268 related articles for article (PubMed ID: 26413786)
1. Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4.
Hirai H; Firpo M; Kikyo N
Stem Cell Res; 2015 Nov; 15(3):469-480. PubMed ID: 26413786
[TBL] [Abstract][Full Text] [Related]
2. Derivation of LIF-independent mouse iPS cells with modified Oct4.
Hirai H; Firpo M; Kikyo N
Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720
[TBL] [Abstract][Full Text] [Related]
3. CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells.
Hasegawa Y; Takahashi N; Forrest AR; Shin JW; Kinoshita Y; Suzuki H; Hayashizaki Y
Stem Cells; 2011 Aug; 29(8):1196-205. PubMed ID: 21681859
[TBL] [Abstract][Full Text] [Related]
4. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
5. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
[TBL] [Abstract][Full Text] [Related]
6. Mouse primed embryonic stem cells could be maintained and reprogrammed on human amnion epithelial cells.
Chen YF; Dong Z; Jiang L; Lai D; Guo L
Stem Cells Dev; 2013 Jan; 22(2):320-9. PubMed ID: 22985337
[TBL] [Abstract][Full Text] [Related]
7. Efficient iPS cell production with the MyoD transactivation domain in serum-free culture.
Hirai H; Katoku-Kikyo N; Karian P; Firpo M; Kikyo N
PLoS One; 2012; 7(3):e34149. PubMed ID: 22479546
[TBL] [Abstract][Full Text] [Related]
8. Positioning canine induced pluripotent stem cells (iPSCs) in the reprogramming landscape of naïve or primed state in comparison to mouse and human iPSCs.
Menon DV; Bhaskar S; Sheshadri P; Joshi CG; Patel D; Kumar A
Life Sci; 2021 Jan; 264():118701. PubMed ID: 33130086
[TBL] [Abstract][Full Text] [Related]
9. n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation.
Liu SP; Harn HJ; Chien YJ; Chang CH; Hsu CY; Fu RH; Huang YC; Chen SY; Shyu WC; Lin SZ
PLoS One; 2012; 7(9):e44024. PubMed ID: 22970157
[TBL] [Abstract][Full Text] [Related]
10. Induced Pluripotent Stem Cells With Six Reprogramming Factors From Prairie Vole, Which Is an Animal Model for Social Behaviors.
Katayama M; Hirayama T; Horie K; Kiyono T; Donai K; Takeda S; Nishimori K; Fukuda T
Cell Transplant; 2016; 25(5):783-96. PubMed ID: 26777120
[TBL] [Abstract][Full Text] [Related]
11. Porcine induced pluripotent stem cells analogous to naïve and primed embryonic stem cells of the mouse.
Telugu BP; Ezashi T; Roberts RM
Int J Dev Biol; 2010; 54(11-12):1703-11. PubMed ID: 21305472
[TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/Akt‑dependent Tbx‑3 activation pathway.
Ke M; He Q; Hong D; Li O; Zhu M; Ou WB; He Y; Wu Y
Int J Mol Med; 2018 Jul; 42(1):131-140. PubMed ID: 29620145
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of chimpanzee fibroblasts into a multipotent cancerous but not fully pluripotent state by transducing iPSC factors in 2i/LIF culture.
Lin ZY; Nakai R; Hirai H; Kozuka D; Katayama S; Nakamura SI; Okada S; Kitajima R; Imai H; Okano H; Imamura M
Differentiation; 2020; 112():67-76. PubMed ID: 32045848
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
Deng W; Cao X; Chen J; Zhang Z; Yu Q; Wang Y; Shao G; Zhou J; Gao X; Yu J; Xu X
ACS Appl Mater Interfaces; 2015 Sep; 7(34):18957-66. PubMed ID: 26269400
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming pig fetal fibroblasts reveals a functional LIF signaling pathway.
Thomson AJ; Pierart H; Meek S; Bogerman A; Sutherland L; Murray H; Mountjoy E; Downing A; Talbot R; Sartori C; Whitelaw CB; Freeman TC; Archibald AL; Burdon T
Cell Reprogram; 2012 Apr; 14(2):112-22. PubMed ID: 22339199
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor-mediated signaling regulates pluripotency markers and lineage differentiation.
Gupta MK; De Jesus DF; Kahraman S; Valdez IA; Shamsi F; Yi L; Swensen AC; Tseng YH; Qian WJ; Kulkarni RN
Mol Metab; 2018 Dec; 18():153-163. PubMed ID: 30316806
[TBL] [Abstract][Full Text] [Related]
17. Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.
Bose B; Shenoy P S
Stem Cell Rev Rep; 2016 Feb; 12(1):73-89. PubMed ID: 26358783
[TBL] [Abstract][Full Text] [Related]
18. Bcl3 Bridges LIF-STAT3 to Oct4 Signaling in the Maintenance of Naïve Pluripotency.
Chen CY; Lee DS; Yan YT; Shen CN; Hwang SM; Lee ST; Hsieh PC
Stem Cells; 2015 Dec; 33(12):3468-80. PubMed ID: 26303070
[TBL] [Abstract][Full Text] [Related]
19. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
20. A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition.
Huang B; Li T; Alonso-Gonzalez L; Gorre R; Keatley S; Green A; Turner P; Kallingappa PK; Verma V; Oback B
PLoS One; 2011; 6(9):e24501. PubMed ID: 21912700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
